The data published in NEJM highlight the positive Phase 3 VALIANT results at Week 26, which were consistent across adolescent and adult patients with C3G and primary IC-MPGN, including patients with ...
Sale of Processor Assets: On September 16, 2025, the Company sold the QRails processor assets recording a $1.2 million loss on sale. XTM retained all QRails EWA assets, including EWA technology, ...
The development firms that own the former Greyhound block in downtown Denver have made one of the largest requests of the ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...
CleanSpark shows Q4 growth, strong FY25 revenue and margins, major power capacity and active hyperscaler talks. Learn why ...
Extra MSA and Gridserve are joining forces to bolster EV charging on the motorway network with seven all-new Super Hubs at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback